Literature DB >> 26014153

Surgical Management of Small Bowel Neuroendocrine Tumors: Specific Requirements and Their Impact on Staging and Prognosis.

Arnaud Pasquer1, Thomas Walter2,3,4, Valérie Hervieu3,5,4, Julien Forestier2, Jean-Yves Scoazec3, Catherine Lombard-Bohas2, Gilles Poncet3,6,4.   

Abstract

BACKGROUND: Small bowel neuroendocrine tumors (SB-NETs) are characterized by two main features: they usually are metastatic at diagnosis and multiple in 30 % of cases. As such, SB-NETs require specific surgical management. This retrospective study examined local recurrence, survival, and prognosis of SB-NETs after adapted surgery.
METHODS: All consecutive patients with SB-NETs who underwent resection of at least one primary tumor between 1 January 2000 and 1 January 2013 were analyzed. The preoperative morphologic workup, histologic classification, and metastatic lymph node (LN) ratio (LNs involved/removed) were recorded.
RESULTS: The study enrolled 107 patients, 35 (33 %) of whom had multiple SB-NETs (range 1-44; mean 3.1). Preoperative imaging and perioperative surgical examination missed 61 and 33 % of SB-NETs, respectively, in contrast to pathologic examination. Of the 107 patients, 43 % had carcinoid syndrome, 70 % had metastatic disease, and 90 % had LN involvement. The median number of LNs retrieved was 12 (range 1-69). The LN ratio (LNs involved/removed) was 0.25. The highest tumoral grades were G1 (in 61 % of patients) and G2 (in 37 % of patients). Of the 107 patients, 13 (12 %) had local LN recurrence. The rate of LN recurrence-free survival at 5 years was 88 %. The median overall survival (OS) time was 128 months (range 91-165 months). In the multivariate analysis, high chromogranin A (CgA) levels and peritoneal carcinomatosis were significantly associated with shorter OS.
CONCLUSIONS: Systematic palpation of the entire small bowel detects more multiple NETs than preoperative imaging. Systematic surgery with extensive LN resection is associated with low local recurrence. High CgA levels and carcinomatosis are linked with shorter survival.

Entities:  

Mesh:

Year:  2015        PMID: 26014153     DOI: 10.1245/s10434-015-4620-2

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  10 in total

1.  Optimal Lymphadenectomy in Small Bowel Neuroendocrine Tumors: Analysis of the NCDB.

Authors:  Benjamin M Motz; Patrick D Lorimer; Danielle Boselli; Joshua S Hill; Jonathan C Salo
Journal:  J Gastrointest Surg       Date:  2017-08-17       Impact factor: 3.452

Review 2.  [Surgical aspects of neuroendocrine tumors of the small intestine].

Authors:  F Weber; H Dralle
Journal:  Chirurg       Date:  2018-06       Impact factor: 0.955

Review 3.  Current status of surgical management of patients with gastroenteropancreatic neuroendocrine neoplasms.

Authors:  Rafał Stankiewicz; Michał Grąt
Journal:  World J Gastrointest Surg       Date:  2022-04-27

Review 4.  Current updates and future directions in diagnosis and management of gastroenteropancreatic neuroendocrine neoplasms.

Authors:  Andrew Canakis; Linda S Lee
Journal:  World J Gastrointest Endosc       Date:  2022-05-16

Review 5.  Curative and palliative surgery in patients with neuroendocrine tumors of the gastro-entero-pancreatic (GEP) tract.

Authors:  Peter E Goretzki; Martina T Mogl; Aycan Akca; Johann Pratschke
Journal:  Rev Endocr Metab Disord       Date:  2018-06       Impact factor: 6.514

Review 6.  Neuroendocrine Neoplasms of the Small Bowel and Pancreas.

Authors:  Ashley Kieran Clift; Mark Kidd; Lisa Bodei; Christos Toumpanakis; Richard P Baum; Kjell Oberg; Irvin M Modlin; Andrea Frilling
Journal:  Neuroendocrinology       Date:  2019-09-27       Impact factor: 5.135

7.  Survival outcomes and surgical intervention of small intestinal neuroendocrine tumors: a population based retrospective study.

Authors:  Lunpo Wu; Jianfei Fu; Li Wan; Jie Pan; Sanchuan Lai; Jing Zhong; Daniel C Chung; Liangjing Wang
Journal:  Oncotarget       Date:  2017-01-17

8.  Multifocal neuroendocrine tumour of the small bowel presenting as an incarcerated incisional hernia: a surgical challenge in a high-risk patient.

Authors:  Kira Steinkraus; Julian R Andresen; Ashley K Clift; Marc O Liedke; Andrea Frilling
Journal:  J Surg Case Rep       Date:  2021-06-16

9.  Intraoperative carcinoid syndrome during small-bowel neuroendocrine tumour surgery.

Authors:  Myrtille Fouché; Yves Bouffard; Mary-Charlotte Le Goff; Johanne Prothet; François Malavieille; Pierre Sagnard; Françoise Christin; Davy Hayi-Slayman; Arnaud Pasquer; Gilles Poncet; Thomas Walter; Thomas Rimmelé
Journal:  Endocr Connect       Date:  2018-12       Impact factor: 3.335

10.  Postoperative morbidity and mortality after surgical resection of small bowel neuroendocrine neoplasms: A systematic review and meta-analysis.

Authors:  Enes Kaçmaz; Jeffrey W Chen; Pieter J Tanis; Els J M Nieveen van Dijkum; Anton F Engelsman
Journal:  J Neuroendocrinol       Date:  2021-07-08       Impact factor: 3.627

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.